MedTrace Logo

Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery

NCT00744861 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2021-04-02

Study results available
· View outcomes & findings →

Summary

Adjunct therapy for increasing posterolateral fusion success following single level posterior instrumented lumbar surgery.

Conditions

  • Lumbar Degenerative Disc Disease

Interventions

DEVICE

Exospine sham

Inactive Exospine LIPUS device (dual transducers)

DEVICE

Exospine

Active Exospine LIPUS device (dual transducers)

DEVICE

Exogen 4000+

Active Exogen LIPUS device (single transducer)

DEVICE

Exogen 4000+ sham

Inactive Exogen 4000+ LIPUS device (single transducer)

Sponsors & Collaborators

  • Bioventus LLC

    lead INDUSTRY

Principal Investigators

  • Jeffrey Fischgrund, MD · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00744861 on ClinicalTrials.gov